BI

BVF Inc Portfolio holdings

AUM $2.8B
1-Year Est. Return 17.96%
This Quarter Est. Return
1 Year Est. Return
+17.96%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$986M
AUM Growth
+$157M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
51
New
Increased
Reduced
Closed

Top Buys

1
+$85.5M
2
+$44.8M
3
+$27M
4
RCUS icon
Arcus Biosciences
RCUS
+$19.6M
5
CRVS icon
Corvus Pharmaceuticals
CRVS
+$17.2M

Top Sells

1
+$59.1M
2
+$23.7M
3
+$21.7M
4
XENE icon
Xenon Pharmaceuticals
XENE
+$14.1M
5
CASC
Cascadian Therapeutics, Inc.
CASC
+$11.6M

Sector Composition

1 Healthcare 83.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$97.9M 9.93%
7,201,316
-386,100
2
$85.5M 8.67%
+6,617,626
3
$82.6M 8.38%
5,062,768
-3,623,730
4
$60.1M 6.09%
655,611
-111,743
5
$47.3M 4.8%
16,436,912
6
$46M 4.66%
3,233,618
7
$44.8M 4.54%
+2,419,443
8
$44.2M 4.49%
1,932,123
-37,666
9
$41.2M 4.18%
5,721,888
10
$40.2M 4.07%
386,065
-208,332
11
$30.4M 3.08%
1,502,800
12
$27M 2.74%
+902,000
13
$27M 2.74%
6,929,690
-1,666,667
14
$25.4M 2.57%
1,353,846
15
$24.5M 2.48%
44,907
+12,112
16
$22.6M 2.29%
43,326
17
$22.5M 2.28%
1,954,254
+1,494,858
18
$20.5M 2.08%
9,766,508
19
$19.6M 1.99%
+1,269,788
20
$14.9M 1.52%
1,048,958
+19,773
21
$13.6M 1.37%
4,106,200
+2,636,400
22
$13.5M 1.37%
4,253,189
-18,100
23
$13.1M 1.33%
62,500
24
$12.8M 1.3%
208,062
+2,193
25
$10.8M 1.1%
103,333
1
2